Literals
- ou:categoriaSJR
- Molecular Medicine (Q2)
- Genetics (Q2)
- Pharmacology (Q2)
- dcterms:coverage
- 2000-2020
- ou:codigoRevista
- 1744-8042
- 1462-2416
- vcard:country-name
- United Kingdom
- bibo:eissn
- 1744-8042
- dcterms:identifier
- 2009-4809
- bibo:issn
- 1462-2416
- dcterms:publisher
- Future Medicine Ltd.
- vcard:region
- Western Europe
- ou:sjrMejorCuartil
- Q2
- dcterms:title
- PHARMACOGENOMICS
Typed Literals
- ou:sjr
- 1.051 (http://www.w3.org/2001/XMLSchema#Decimal)
Inverse Relations
- Has related:
ou:publicadaEnRevista
- CYP2D6 genotyping for psychiatric patients treated with risperidone: Considerations for cost-effectiveness studies
- Development of a new genotyping assay for detection of the BDNF Val66Met polymorphism using melting-curve analysis
- Histamine pharmacogenomics
- Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity
- Relation between CYP2D6 genotype, personality, neurocognition and overall psychopathology in healthy volunteers
- Relevance of CYP2D6 -1584C>G polymorphism for thioridazine:mesoridazine plasma concentration ratio in psychiatric patients